Godtfredsen WO, Jahnsen S, Lorck H, Roholt K, Tybring L, Fusidic acid: a new antibiotic, in Nature, vol. 193, marzo 1962, p. 987, PMID13899435.
Godtfredsen W, Roholt K, Tybring L, Fucidin: a new orally active antibiotic, in Lancet, vol. 1, n. 7236, maggio 1962, pp. 928–31, PMID13899434.
(DA) Godtfredsen WO, Lorck H, Roholt K, Tybring L, [Fucidin, a new antibiotic for peroral therapy], in Ugeskr. Laeg., vol. 124, maggio 1962, pp. 715–9, PMID13899436.
Arigoni D, von Daehne W, Godtfredsen WO, Melera A, Vangedal S, The stereochemistry of fusidic acid, in Experientia, vol. 20, n. 6, giugno 1964, pp. 344–7, PMID5855867.
Godtfredsen WO, von Daehne W, Vangedal S, Marquet A, Arigoni D, Melera A, The stereochemistry of fusidic acid, in Tetrahedron, vol. 21, n. 12, dicembre 1965, pp. 3505–30, PMID5879166.
Vasta M, [A new antibiotic: fusidic acid], in Boll Chim Farm, vol. 101, novembre 1962, pp. 885–7, PMID13996455.
Parsons RL, Hossack G, Paddock G, The absorption of antibiotics in adult patients with coeliac disease, in J. Antimicrob. Chemother., vol. 1, n. 1, marzo 1975, pp. 39–50, PMID1176375.
Wright GL, Harper J, Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis, in Lancet, vol. 1, n. 7636, gennaio 1970, pp. 9–14, PMID4188384.
Copperman IJ, The prolonged use of intravenous fusidic acid in severe staphylococcal infection, in Br J Clin Pract, vol. 26, n. 2, febbraio 1972, pp. 83–4, PMID5016911.
Kotowski J, Treatment of axillary abscesses with fusidic acid gel, in Practitioner, vol. 222, n. 1328, febbraio 1979, pp. 269–71, PMID372941.
Bendtzen K, Vesti-Nielsen N, Petersen J, Andersen V, Bendixen G, Treatment of chronic endogenous uveitis with fusidic acid, in Lancet, vol. 337, n. 8740, marzo 1991, pp. 552–3, PMID1671912.
Langholz E, Brynskov J, Freund LG, Bendtzen K, Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy, in Dan Med Bull, vol. 38, n. 3, giugno 1991, p. 284, PMID1868757.
Christiansen K, Fusidic acid non-antibacterial activity, in Int. J. Antimicrob. Agents, 12 Suppl 2, agosto 1999, pp. S73–8, PMID10528789.
(PL) Owczarek W, Wydrzyńska A, Paluchowska E, [Antibiotic therapy in skin diseases], in Pol. Merkur. Lekarski, vol. 30, n. 179, maggio 2011, pp. 367–72, PMID21675145.
Voetmann E, Fusidic acid treatment in psoriasis, in Lancet, vol. 2, n. 7721, agosto 1971, p. 435, PMID4105206.
Natarajan S, Paily PP, Fusidic acid in psoriasis, in Lancet, vol. 2, n. 7737, dicembre 1971, p. 1322, PMID4143569.
Nyfors A, Fucidin in psoriasis. A double-blind study of twenty psoriatics over two periods of four weeks each, in Dermatologica, vol. 146, n. 5, 1973, pp. 281–4, PMID4583782.
Vickers CF, Percutaneous absorption of sodium fusidate and fusidic acid, in Br. J. Dermatol., vol. 81, n. 12, dicembre 1969, pp. 902–8, PMID5359453.
McAreavey D, Redding PJ, Staphylococcal septicaemia complicated by probable cloxacillin neurotoxicity and by jaundice induced by fusidic acid, in Scott Med J, vol. 28, n. 2, aprile 1983, pp. 179–80, PMID6867701.
El-Kassar N, Kalfon P, Fromont P, et al., Fusidic acid induced acute immunologic thrombocytopenia, in Br. J. Haematol., vol. 93, n. 2, maggio 1996, pp. 427–31, PMID8639443.
Raab W, Windisch J, The effect of hydrocortisone, a steroid hormone, on antibacterial activity of fusidic acid, a steroid antibiotic, in Pathol Microbiol (Basel), vol. 34, n. 1, 1969, pp. 52–9, PMID4905988.